Image

Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina

Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

ORBITA-FIRE is a randomised, double-blinded, placebo controlled experimental study that will identify the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) thresholds that correlate with symptoms of angina for 58 patients measured invasively under experimental conditions.

Eligibility

Inclusion Criteria:

  • Eligibility for percutaneous coronary intervention (PCI) due to angina or angina-equivalent symptoms on exertion
  • Anatomical evidence of significant single-vessel coronary stenosis defined by either:
    • ≥70% stenosis on invasive coronary angiography (ICA)
    • Severe stenosis on CT coronary angiography (CTCA)
  • Physiological evidence of ischaemia with a positive test on at least one of the
    following
    • Stress echocardiography
    • Cardiac magnetic resonance perfusion
    • Myocardial perfusion scintigraphy
    • Invasive metrics of coronary physiology

Exclusion Criteria:

  • Age <18 years
  • Recent acute coronary syndrome
  • Previous coronary artery by-pass graft
  • Significant left main stem disease
  • Multivessel disease (defined as >50% angiographic stenosis in other vessels)
  • Chronic total occlusion in the target artery
  • Moderate to severe valvular disease
  • Moderate to severe left ventricular impairment
  • Chronotropic incompetence with a pacemaker
  • Contraindication to PCI or a drug-eluting stents
  • Contraindication to antiplatelet therapy
  • Contraindication to adenosine
  • Moderate to severe respiratory disease
  • Physical inability to exercise
  • Pregnant
  • Inability to consent

Study details
    Stable Angina

NCT05459051

Imperial College London

7 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.